NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Appoints Suja Chandrasekaran and Scott Mendel to Board of Directors, Strengthening Advisory Group to Support Company Momentum
IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – January 6, 2022 – Agendia, Inc., a commercial stage company focused on precision oncology for breast cancer, today announced the appointment of healthcare industry veterans Suja Chandrasekaran, MS Read More
Agendia Spotlight Poster at SABCS 2021 Confirms Utility of BluePrint as Biomarker Subtyping Test to Guide Neoadjuvant Chemotherapy Decisions
Additional research from the real-world FLEX Registry focuses on age effect and lymph node status for patients with breast cancer IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – December 10, 2021 – Agendia, Inc., a world Read More
Analysis Presented at SABCS 2021 Confirms MammaPrint and BluePrint Predict Outcomes Following Neoadjuvant Chemotherapy
Data signal importance of serial genomic testing in order to appropriately adjust breast cancer treatment plans IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – December 9, 2021 – Agendia, Inc., a world leader in precision oncology Read More